METTL3 and hepatocellular carcinoma: It is known that lipid deposition in HCC is regulated by carboxylesterase 2 (CES2), and METTL3 can reduce the level of CES2 and promote the expression of fat complexes and coordinate to deposit lipids [96, 101].